CYP19A1 and neoplasm: The implication of 5α‐reductases and aromatase in the growth of androgen and oestrogen‐sensitive tumours, such as prostate, breast and GB cancers, suggested that these steroidogenic enzymes are expressed in GB‐derived cells.